News >

Mounting Advances Make Waves Across Myeloma Spectrum

Caroline Seymour
Published: Friday, Sep 20, 2019

Sarah M. Larson, MD, a professor in the Department of Medical Oncology, University of Washington School of Medicine, and clinical trials core director, Genitourinary Medical Oncology, Seattle Cancer Care Alliance

Sarah M. Larson, MD

Although one school of thought in the multiple myeloma paradigm is not to put the most potent regimens upfront, Sarah M. Larson, MD, disagrees with this sequencing approach.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication